Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mol Endocrinol ; 15(11): 1929-40, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11682624

RESUMO

Steroid hormone receptors and signal transducers and activators of transcription (STAT) factors constitute two distinct families of transcription factors activated by different signaling pathways. In previous reports, cross-talk between STAT5 and several steroid receptors has been demonstrated. We investigated putative cross-talk between ERalpha and ERbeta and STAT5. ERalpha and ERbeta were found to potently repress PRL-induced STAT5 transcriptional activity on a beta-casein promoter construct in a ligand-dependent manner. This down-regulation was found to rely on direct physical interaction between the ERs and STAT5, mediated via the ER DNA-binding domain (DBD). The contact between the ER DBD and STAT5 is highly specific; the interaction is abolished if the ERalpha DBD is replaced with the DBD of a closely related steroid receptor. The physical interaction, however, is insufficient to confer the repression of STAT5 activity, which in addition requires the ligand-activated C-terminal part of the ERs, although these domains are not in direct contact with STAT5. Negative cross-talk between ERs and STAT5 is thus mediated via several functionally separated domains of the ERs. Our findings may enhance the understanding of mechanisms of regulation of the different hormonal signaling pathways occurring during different functional events in tissues coexpressing ERs and STAT5.


Assuntos
Proteínas de Ligação a DNA/metabolismo , Proteínas do Leite , Receptores de Estrogênio/metabolismo , Transdução de Sinais , Transativadores/metabolismo , Animais , Sítios de Ligação , Caseínas/genética , Células Cultivadas , Proteínas de Ligação a DNA/efeitos dos fármacos , Proteínas de Ligação a DNA/genética , Regulação para Baixo , Receptor alfa de Estrogênio , Receptor beta de Estrogênio , Humanos , Camundongos , Prolactina/metabolismo , Prolactina/farmacologia , Regiões Promotoras Genéticas , Receptores de Estrogênio/efeitos dos fármacos , Receptores de Estrogênio/genética , Receptores da Prolactina/genética , Receptores da Prolactina/metabolismo , Fator de Transcrição STAT5 , Transativadores/efeitos dos fármacos , Transativadores/genética , Transcrição Gênica , Proteínas Supressoras de Tumor
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...